| Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer RJ Kelly, JA Ajani, J Kuzdzal, T Zander, E Van Cutsem, G Piessen, ... New England Journal of Medicine 384 (13), 1191-1203, 2021 | 1052 | 2021 |
| Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors C Rousseaux, X Thuru, A Gelot, N Barnich, C Neut, L Dubuquoy, ... Nature medicine 13 (1), 35-37, 2007 | 960 | 2007 |
| Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus JA Jankowski, NA Wright, SJ Meltzer, G Triadafilopoulos, K Geboes, ... The American journal of pathology 154 (4), 965-973, 1999 | 544 | 1999 |
| Effect of early and systematic integration of palliative care in patients with advanced cancer: a randomised controlled trial G Vanbutsele, K Pardon, S Van Belle, V Surmont, M De Laat, R Colman, ... The Lancet Oncology 19 (3), 394-404, 2018 | 444 | 2018 |
| First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE … HS Wasan, P Gibbs, NK Sharma, J Taieb, V Heinemann, J Ricke, ... The Lancet Oncology 18 (9), 1159-1171, 2017 | 375 | 2017 |
| Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a … RK Kelley, M Ueno, C Yoo, RS Finn, J Furuse, Z Ren, T Yau, HJ Klümpen, ... The Lancet 401 (10391), 1853-1865, 2023 | 230 | 2023 |
| Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised … CS Fuchs, K Shitara, M Di Bartolomeo, S Lonardi, SE Al-Batran, ... The Lancet Oncology 20 (3), 420-435, 2019 | 229 | 2019 |
| Erosive enterocolitis in mycophenolate mofetil-treated renal-transplant recipients with persistent afebrile diarrhea BD Maes, I Dalle, K Geboes, M Oellerich, VW Armstrong, P Evenepoel, ... Transplantation 75 (5), 665-672, 2003 | 180 | 2003 |
| Amount and fate of egg protein escaping assimilation in the small intestine of humans P Evenepoel, D Claus, B Geypens, M Hiele, K Geboes, P Rutgeerts, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 277 (5 …, 1999 | 174 | 1999 |
| Abatacept for Crohn's disease and ulcerative colitis WJ Sandborn, JF Colombel, BE Sands, P Rutgeerts, SR Targan, ... Gastroenterology 143 (1), 62-69. e4, 2012 | 155 | 2012 |
| Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases S De Bruyne, N Van Damme, P Smeets, L Ferdinande, W Ceelen, ... British journal of cancer 106 (12), 1926-1933, 2012 | 136 | 2012 |
| Vascular anatomy of the gastrointestinal tract K Geboes, KP Geboes, G Maleux Best Practice & Research Clinical Gastroenterology 15 (1), 1-14, 2001 | 129 | 2001 |
| Laparoscopic liver resection compared to open approach in patients with colorectal liver metastases improves further resectability: Oncological outcomes of a case-control … R Montalti, G Berardi, S Laurent, S Sebastiani, L Ferdinande, LJ Libbrecht, ... European Journal of Surgical Oncology 40 (5), 536-544, 2014 | 128 | 2014 |
| The in vivo use of the stable isotope-labelled biomarkers lactose-[15N] ureide and [2H4] tyrosine to assess the effects of pro-and prebiotics on the intestinal flora of healthy … V De Preter, K Geboes, K Verbrugghe, L De Vuyst, T Vanhoutte, G Huys, ... British Journal of Nutrition 92 (3), 439-446, 2004 | 126 | 2004 |
| Evidence for the involvement of infectious agents in the pathogenesis of Crohn’s disease G De Hertogh, J Aerssens, KP Geboes, K Geboes World journal of gastroenterology: WJG 14 (6), 845, 2008 | 115 | 2008 |
| Increased expression of CD146, a new marker of the endothelial junction in active inflammatory bowel disease N Bardin, D Reumaux, K Geboes, JF Colombel, M Blot-Chabaud, ... Inflammatory bowel diseases 12 (1), 16-21, 2006 | 107 | 2006 |
| The effect of early and systematic integration of palliative care in oncology on quality of life and health care use near the end of life: a randomised controlled trial G Vanbutsele, S Van Belle, V Surmont, M De Laat, R Colman, K Eecloo, ... European Journal of Cancer 124, 186-193, 2020 | 94 | 2020 |
| A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE) JP Machiels, R Salazar, S Rottey, I Duran, L Dirix, K Geboes, ... Journal for immunotherapy of cancer 7, 1-15, 2019 | 92 | 2019 |
| Crohn's‐like changes in the colon due to mycophenolate? IJ Dalle, BD Maes, KP Geboes, W Lemahieu, K Geboes Colorectal Disease 7 (1), 27-34, 2005 | 85 | 2005 |
| Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials N Charette, C Vandeputte, L Ameye, CV Bogaert, J Krygier, T Guiot, ... BMC cancer 19, 1-9, 2019 | 84 | 2019 |
